SPDWvsXBI
SPDR Portfolio Developed World ex-US ETF against SPDR S&P Biotech ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| SPDW | XBI | |
|---|---|---|
| Expense ratio | 0.030% | 0.35% |
| Assets | $41.1B | $10.4B |
| Net flow, 1 month | — | −$690M |
| Net flow, 1 year | +$5B | +$1.1B |
| Return, YTD | +12.4% | +26.7% |
| Return, 1 year | +15.7% | +52.4% |
| Avg daily volume | 2.6M | 8.6M |
| Holdings | 2480 | 135 |
| Listed | Apr 20, 2007 | Jan 31, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS